fig8
Figure 8. Myocardial infarction size. (A) Representative Masson’s trichrome staining of heart sections at the midventricular level of each treatment group. (B) Comparative quantification of infarct size percentage. Placebo n = 12, WJMSC-EV-PLT n = 12, WJMSC-EV-FBS n = 7. *P < 0.05. WJMSC: Wharton’s Jelly-derived mesenchymal stem cell; EV: extracellular vesicle; PLT: human platelet lysate; FBS: fetal bovine serum.
